Valuation: Artivion, Inc.

Market Cap 1.31B 1.13B 1.05B 970M 1.83B 124B 1.85B 12.39B 4.86B 62.13B 4.9B 4.8B 206B P/E 2026 *
321x
P/E 2027 * 66x
Enterprise Value 1.31B 1.13B 1.05B 970M 1.83B 124B 1.85B 12.39B 4.86B 62.13B 4.9B 4.8B 206B EV / Sales 2026 *
2.69x
EV / Sales 2027 * 2.42x
Free-Float
89.39%
Yield 2026 *
-
Yield 2027 * -
1 day-4.62%
1 week-0.85%
Current month-3.31%
1 month+12.50%
3 months-23.03%
6 months-30.67%
Current year-40.08%
1 week 23.4
Extreme 23.4
24.2
1 month 20
Extreme 20
24.2
Current year 17.4
Extreme 17.4
38.9
1 year 17.4
Extreme 17.4
41.1
3 years 11.7
Extreme 11.7
41.1
5 years 10.1
Extreme 10.1
41.1
10 years 10.1
Extreme 10.1
41.1
Manager TitleAgeSince
Chief Executive Officer 59 02/09/2014
Director of Finance/CFO 53 04/12/2023
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 71 01/12/2003
Director/Board Member 66 01/12/2003
Director/Board Member 61 01/05/2012
Change 5-day change 1-year change 3-year change Capi.($)
-4.62%-0.85% - - 1.31B
-0.66%-3.03%-19.86%-3.43% 182B
-0.83%-2.31%-4.63%+0.94% 110B
+4.04%+0.14%+9.13%+71.00% 59.59B
-0.10%+9.35%+43.37%+59.19% 55.04B
-0.98%+0.03%-4.77%-38.79% 46.87B
-15.93%-11.26% - - 35.55B
-5.12%+10.05%+9.58%-31.64% 32.81B
+0.24%+3.57%+46.33%-7.71% 24.54B
-1.53%-2.34%+2.44%+1.39% 22.69B
Average -2.53%+3.89%+10.20%+6.37% 63.33B
Weighted average by Cap. -1.37%+1.55%+0.15%+7.40%

Financials

2026 *2027 *
Net sales 486M 421M 393M 361M 682M 46.23B 689M 4.61B 1.81B 23.13B 1.83B 1.79B 76.62B 540M 468M 436M 401M 757M 51.33B 765M 5.12B 2.01B 25.68B 2.03B 1.98B 85.05B
Net income 4.4M 3.81M 3.55M 3.27M 6.17M 418M 6.24M 41.74M 16.38M 209M 16.53M 16.16M 693M 22.59M 19.56M 18.24M 16.77M 31.66M 2.15B 32.02M 214M 84.11M 1.07B 84.83M 82.96M 3.56B
Net Debt - -
Logo Artivion, Inc.
Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeons in treating patients with aortic diseases. The Company operates through two segments, which include Medical Devices and Preservation Services. The Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other products. The Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. It has four product families: aortic stent grafts, On-X mechanical heart valves and related surgical products, surgical sealants, and implantable cardiac and vascular human tissues. Its aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Its surgical sealants include BioGlue Surgical Adhesive products. It is engaged in the endovascular repair of aortic arch disease and the developer of the NEXUS Aortic Arch System.
Employees
1,800
Date Price Change
05/08/26 23.40 -1.68%
04/08/26 €23.80 0.00%
03/08/26 €23.80 -1.65%
31/07/26 €24.20 +0.83%
30/07/26 €24.00 +1.69%
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
26.90USD
Average target price
42.00USD
Spread / Average Target
+56.13%

Quarterly revenue - Rate of surprise